Impax Asset Management Group’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$29.6M Sell
260,208
-20,000
-7% -$2.27M 0.17% 91
2025
Q1
$29.5M Hold
280,208
0.18% 93
2024
Q4
$30M Hold
280,208
0.14% 105
2024
Q3
$28M Hold
280,208
0.11% 113
2024
Q2
$23.6M Buy
280,208
+25,000
+10% +$2.11M 0.1% 119
2024
Q1
$18.7M Buy
255,208
+50,000
+24% +$3.66M 0.07% 134
2023
Q4
$14.7M Buy
205,208
+20,888
+11% +$1.49M 0.06% 139
2023
Q3
$11M Buy
184,320
+25,000
+16% +$1.5M 0.05% 156
2023
Q2
$11.5M Sell
159,320
-35,000
-18% -$2.52M 0.05% 151
2023
Q1
$14.3M Sell
194,320
-40,000
-17% -$2.94M 0.06% 136
2022
Q4
$15.7M Sell
234,320
-141,295
-38% -$9.44M 0.07% 128
2022
Q3
$20.2M Buy
375,615
+80,150
+27% +$4.31M 0.1% 117
2022
Q2
$16.4M Buy
295,465
+32,060
+12% +$1.78M 0.08% 126
2022
Q1
$18.5M Buy
263,405
+47,289
+22% +$3.32M 0.08% 127
2021
Q4
$20.8M Buy
216,116
+56,906
+36% +$5.48M 0.08% 126
2021
Q3
$13.8M Buy
159,210
+32,060
+25% +$2.79M 0.06% 133
2021
Q2
$10.4M Sell
127,150
-8,161
-6% -$668K 0.05% 151
2021
Q1
$12.9M Sell
135,311
-65,973
-33% -$6.27M 0.07% 123
2020
Q4
$12.5M Hold
201,284
0.08% 113
2020
Q3
$12M Buy
201,284
+14,007
+7% +$833K 0.1% 110
2020
Q2
$13.1M Hold
187,277
0.13% 104
2020
Q1
$8.5M Buy
187,277
+64,120
+52% +$2.91M 0.11% 113
2019
Q4
$8.01M Buy
123,157
+7,255
+6% +$472K 0.09% 134
2019
Q3
$7.2M Hold
115,902
0.09% 141
2019
Q2
$8.25M Sell
115,902
-13,875
-11% -$988K 0.11% 120
2019
Q1
$10.2M Hold
129,777
0.14% 115
2018
Q4
$11M Buy
129,777
+80,150
+162% +$6.78M 0.18% 101
2018
Q3
$8.5M Buy
+49,627
New +$8.5M 0.12% 137